![Immunohistochemistry-Paraffin: CTR9 Antibody [NB100-68205] - FFPE section of human breast carcinoma. Affinity purified rabbit anti-CTR9 used at a dilution of 1:250.](https://cdn.sanity.io/images/f5b6mtfn/antibodies-prod/03c82c2fb7d8aed228ee536896cd4d5156863137-400x301.jpg?w=3840&q=75&fit=clip&auto=format)
CTR9 Antibody
- Manufacturer
- Novus Biologicals, LLC
- Catalog Number
- NB100-68205
- Host
- Rabbit
- Reactivity
- Human, Mouse
- Applications
- Immunocytochemistry, Immunohistochemistry, Immunohistochemistry (Paraffin-Embedded Sections), Immunoprecipitation, Western Blotting
![Immunoprecipitation: DDIT4 Antibody [NBP1-22966] - NBF-fixed asynchronous HeLa cells. Cobalt treated cells (left) or mock treated cells (right) immunostained for REDD1. Affinity purified rabbit anti-REDD1 1:100.](https://cdn.sanity.io/images/f5b6mtfn/antibodies-prod/01f953872617a0a2bf58b976b502814949d63938-400x208.jpg?w=3840&q=75&fit=clip&auto=format)
![Western Blot: eIF3X Antibody [NB100-93306] - Samples: Whole cell lysate from HeLa (5, 15 and 50 mcg for WB; 1 mg for IP, 20% of IP loaded) and 293T (T; 50 mcg) cells. Antibody: Affinity purified rabbit anti-eIF3X antibody NB100-93306 used for WB at 0.04 mcg/ml (A) and 1 mcg/ml (B) and used for IP at 3 mcg/mg lysate. eIF3X was also immunoprecipitated by rabbit anti-eIF3X antibody NB100-93305, which recognizes an upstream epitope. For blotting immunoprecipitated eIF3X, the ReliaBLOT (R) Reagents and Procedures (Cat. No. WB120) were used. Detection: Chemiluminescence with exposure times of 3 seconds (A) and 1 second (B).](https://cdn.sanity.io/images/f5b6mtfn/antibodies-prod/6e7f159167bb21d874b984133b3f0babe6aedc8d-400x255.jpg?w=3840&q=75&fit=clip&auto=format)
![Immunohistochemistry-Paraffin: GMEB1 Antibody [NBP1-46207] - Human lung carcinoma (left) and mouse teratoma (right). Antibody used at a dilution of 1:1,000.](https://cdn.sanity.io/images/f5b6mtfn/antibodies-prod/83be247ccd1055d492416a8d44764722eef17690-400x270.jpg?w=3840&q=75&fit=clip&auto=format)
![Immunohistochemistry-Paraffin: UBE2A Antibody [NB100-553] - FFPE section of human stomach adenocarcinoma. Affinity purified rabbit anti-Rad6 used at a dilution of 1:250.](https://cdn.sanity.io/images/f5b6mtfn/antibodies-prod/d31e48f66f49441450e9058070251e296289cf01-400x306.jpg?w=3840&q=75&fit=clip&auto=format)
![Immunohistochemistry-Paraffin: LEO1 Antibody [NB600-276] - Human stomach carcinoma (left) and mouse teratoma (right). Antibody used at a dilution of 1:5,000.](https://cdn.sanity.io/images/f5b6mtfn/antibodies-prod/3e0b99346b6b246d6d0d819d644ccb05f6589c5b-400x184.jpg?w=3840&q=75&fit=clip&auto=format)
![Proximity Ligation Assay: MOV10 Antibody [NB100-77314] - Secondary-conjugate Duolink II PLA in Hela Cells. Goat anti-human RENT1 (NB100-370) and rabbit anti human MOV10 (NB100-77314). Image merged from DAPI (2ms) and Texas Red (200ms) exposures, 40X magnification.](https://cdn.sanity.io/images/f5b6mtfn/antibodies-prod/01c3e7f7531baa97ecd2b24b751523979c7dc430-400x298.jpg?w=3840&q=75&fit=clip&auto=format)
![Immunohistochemistry-Paraffin: Nucleostemin Antibody [NB100-1568] - Human skin carcinoma. Antibody used at a dilution of 1:200.](https://cdn.sanity.io/images/f5b6mtfn/antibodies-prod/a9ef9a02b90c6696798d6674b1be150153467878-396x400.jpg?w=3840&q=75&fit=clip&auto=format)
![Western Blot: NUP214 Antibody [NB100-2245] - Detection of Human and Mouse NUP214 on HeLa whole cell lysate using NB100-2245. NUP214 was also immunoprecipitated using rabbit anti-NUP214 antibody NB100-2244.](https://cdn.sanity.io/images/f5b6mtfn/antibodies-prod/e225c805905838221c502f93186070732b363022-400x252.jpg?w=3840&q=75&fit=clip&auto=format)
![Immunoprecipitation: PRPF8 Antibody [NBP2-22274] - Whole cell lysate (1 mg for IP; 20% of IP loaded) from 293T cells. Antibodies: Affinity purified rabbit anti-PRPF8 antibody NBP2-22274 used for IP at 6 ug/mg lysate. PRPF8 was also immunoprecipitated by rabbit anti-PRPF8 antibodies NBP2-22272 and NBP2-22273 For blotting immunoprecipitated PRPF8, NBP2-22274 was used at 1 ug/ml. Detection: Chemiluminescence with an exposure time of 10 seconds.](https://cdn.sanity.io/images/f5b6mtfn/antibodies-prod/a91c6be1ad0ee30e69158053449a06985d15757b-288x400.jpg?w=3840&q=75&fit=clip&auto=format)
![Western Blot: RNF2 Antibody [NBP1-49966] - Detection of Human and Mouse RNF2 by Western Blot (h&m) and Immunoprecipitation (h). Samples: Whole cell lysate from K562 (5, 15 and 50 mcg for WB; 1 mg for IP, 20% of IP loaded), 293T (T; 50 mcg), and mouse NIH3T3 (M; 50 mcg) cells. Antibodies: Affinity purified rabbit anti-RNF2 antibody used for WB at 0.1 mcg/ml (A) and 1 mcg/ml (B) and used for IP at 3 mcg/mg lysate. RNF2 was also immunoprecipitated by rabbit anti-RNF2 antibody, which recognizes a downstream epitope. For blotting immunoprecipitated RNF2 was used. Detection: Chemiluminescence with exposure times of 30 seconds (A and B).](https://cdn.sanity.io/images/f5b6mtfn/antibodies-prod/7ac792bd15b70f79b836a5ae2aabfa50c1f96c38-400x276.jpg?w=3840&q=75&fit=clip&auto=format)
![Immunohistochemistry-Paraffin: SAFB Antibody [NB100-2593] - FFPE section of human breast adenocarcinoma. Affinity purified rabbit anti-SAFB1 used at a dilution of 1:250.](https://cdn.sanity.io/images/f5b6mtfn/antibodies-prod/2a7773446f00c80b884bee08966c41630e4efb8a-400x305.jpg?w=3840&q=75&fit=clip&auto=format)
![Western Blot: TFIIIC Antibody [NB100-60657] - Detection of Human GTF3C1/TFIIIC220 on HeLa whole cell lysate using NB100-60657. GTF3C1/TFIIIC220 was efficiently IPed by rabbit anti-GTF3C1/TFIIIC220 antibodies NB100-60655 and NB100-60656.](https://cdn.sanity.io/images/f5b6mtfn/antibodies-prod/c03e8598f08efec99f8fd5daa5d39bff9b8a431d-400x208.jpg?w=3840&q=75&fit=clip&auto=format)
![Western Blot: XPB Antibody [NB100-61060] - Detection of Human and Mouse ERCC3 on HeLa whole cell lysate using NB100-61060. ERCC3 was also immunoprecipitated by rabbit anti-ERCC3 antibody NB100-61059.](https://cdn.sanity.io/images/f5b6mtfn/antibodies-prod/949bdd3f01a8ec52e34e50c1cbf9b279ad1251b8-400x253.jpg?w=3840&q=75&fit=clip&auto=format)
![Western Blot: AAAS Antibody (5B10) [NBP2-45540] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY AAAS.](https://cdn.sanity.io/images/f5b6mtfn/antibodies-prod/7e20d2c2af2c9abc53cef630904d80a7e7a6c683-204x400.jpg?w=3840&q=75&fit=clip&auto=format)
![Western Blot: ACD Antibody (2B1) [NBP2-45475] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY ACD.](https://cdn.sanity.io/images/f5b6mtfn/antibodies-prod/891ddd1796dce98bef6e5fcd18cacf133d5ccac1-204x400.jpg?w=3840&q=75&fit=clip&auto=format)
![Western Blot: Angiopoietin-like protein 8/Betatrophin Antibody (1B12) [NBP2-46596] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY Angiopoietin-like protein 8.](https://cdn.sanity.io/images/f5b6mtfn/antibodies-prod/b04c306b6db01ad6794d2dcfea42af2e7a5cc2b6-204x400.jpg?w=3840&q=75&fit=clip&auto=format)
![Western Blot: ANKMY2 Antibody (1F11) [NBP2-46524] - Analysis of extracts (35ug) from 9 different cell lines by using ANKMY2 monoclonal antibody (HepG2: human; HeLa: human; SVT2: mouse; A549: human; COS7: monkey; Jurkat: human; MDCK: canine; PC12: rat; MCF7: human).](https://cdn.sanity.io/images/f5b6mtfn/antibodies-prod/289555054c7a70b59c01579619763b808478eed2-400x257.jpg?w=3840&q=75&fit=clip&auto=format)
![Flow Cytometry: ARL11 Antibody (1A5) [NBP2-01470] - HEK293T cells transfected with either overexpression plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-ARL11 antibody, and then analyzed by flow cytometry.](https://cdn.sanity.io/images/f5b6mtfn/antibodies-prod/d56cc8538c2e679ef0d2a3379bf502a57210e4b2-400x265.jpg?w=3840&q=75&fit=clip&auto=format)
![Flow Cytometry: ARL5B Antibody (2D7) [NBP2-01669] - Analysis of Jurkat cells, using anti-ARL5B antibody, (Red), compared to a nonspecific negative control antibody (Blue).](https://cdn.sanity.io/images/f5b6mtfn/antibodies-prod/816b20aeb7a8beef202c755af79c145476057148-400x266.jpg?w=3840&q=75&fit=clip&auto=format)
![Western Blot: ARPC5 Antibody (2G1) [NBP2-45504] - Analysis of extracts (10ug) from 4 different cell lines.](https://cdn.sanity.io/images/f5b6mtfn/antibodies-prod/2345866c40c592f47d8a338feacafb591ada0c88-295x400.jpg?w=3840&q=75&fit=clip&auto=format)
![Western Blot: ATF1 Antibody (2B4) [NBP2-46552] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY ATF1.](https://cdn.sanity.io/images/f5b6mtfn/antibodies-prod/745017f90dcba7a3a5eb12c5e81bc13982a5332a-204x400.jpg?w=3840&q=75&fit=clip&auto=format)
![Western Blot: B7-H2/ICOSLG Antibody (2C5) [NBP2-46011] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY ICOSLG.](https://cdn.sanity.io/images/f5b6mtfn/antibodies-prod/b90e3bce8c572a65bbe57c07c947e1ed4cc6b9ff-204x400.jpg?w=3840&q=75&fit=clip&auto=format)
![Immunocytochemistry/Immunofluorescence: BCKDK Antibody (11C9) [NBP1-47664] Staining of COS7 cells transiently transfected by pCMV6-ENTRY BCKDK.](https://cdn.sanity.io/images/f5b6mtfn/antibodies-prod/061aeed8297277ba2d9a461f41d50cbfd8a51539-400x302.jpg?w=3840&q=75&fit=clip&auto=format)
![Western Blot: BMF Antibody (6F3) [NBP2-46578] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY BMF .](https://cdn.sanity.io/images/f5b6mtfn/antibodies-prod/9bc3ad630db065ace9d1df7c13df415582f3a0a8-204x400.jpg?w=3840&q=75&fit=clip&auto=format)